{
    "clinical_study": {
        "@rank": "121146", 
        "arm_group": {
            "arm_group_label": "Preterm/low birth weight infants", 
            "description": "Preterm infant formula per standard of care"
        }, 
        "brief_summary": {
            "textblock": "This is a two stage open-label, single-arm, multicenter and observational study.\n\n      Stage 1: In hospital, preterm/low birth weight infants less than or equal to 34 weeks\n      gestational age at birth, birth weight of \u2265 1000g to <1800g and conditions meeting the\n      enrollment criteria will be fed formula with or without parenteral nutrition until\n      discharge. Stage 2: Post-discharge, all infants with birth weight < or =1500g will be\n      followed on formula per standard of care and accepted standard of care including feeding\n      until the infant's weight >or= 25th percentile of growth expectation based on corrected age\n      (P25) or until infant reaches 9 months corrected age."
        }, 
        "brief_title": "Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Preterm Infants", 
        "condition_browse": {
            "mesh_term": "Birth Weight"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria for Stage 1:\n\n          -  Less than or equal to 34 weeks gestational age at birth, and birth weight \u2265 1000g to\n             < 1800g;\n\n          -  Apgar score in 5 minutes after birth \u2265 7;\n\n          -  Infant is 21 days or less of age at enrollment;\n\n          -  Only singleton or twin births;\n\n          -  Infants who can receive early enteral feeding stably (reaching 50% or higher of the\n             required daily total calories) and whose parents/guardians and investigators have\n             selected Similac Special Care (SSC) for feeding;\n\n          -  Infant has been classified as appropriate for gestational age (AGA) or if classified\n             as asymmetric small for gestational age (SGA) (Asymmetric SGA: Weight below the 10th\n             percentile, but head circumference  is greater than or equal to the 10th percentile)\n             enrollment has been preapproved by sponsor;\n\n        Inclusion Criteria for Stage 2:\n\n          -  Infants with birth weight < or = 1500g, subjects whose parents/guardians and\n             investigators have selected NeoSure for continued feeding after hospital discharge.\n\n        Exclusion Criteria for Stage 1:\n\n          -  Serious congenital chromosomal or metabolic abnormalities that may affect growth and\n             development;\n\n          -  Congenital gastrointestinal malformations , including but not limited to congenital\n             megacolon or gastric-intestinal perforation;\n\n          -  Serious complications associated with preterm birth, including but not limited to\n             necrotizing enterocolitis (NEC), septicemia or sepsis;\n\n          -  Other serious disorders of cardiac/respiratory/endocrine/hematological/\n             gastrointestinal/other systems, or serious diseases requiring surgical intervention;\n\n          -  Maternal incapacity: including maternal drug, cocaine or alcohol abuse during\n             pregnancy or current;\n\n          -  Infants who received any experimental treatment, participated in other clinical\n             trials or received other study interventions unrelated to this study within 30 days\n             prior to enrollment;\n\n          -  Infants who have received or planned to receive breastfeeding or other infant formula\n             (powder) other than SSC with calories  intake  \u226525%  of the required daily total\n             calories\n\n          -  Intubation for ventilation at the time of enrollment.\n\n        Exclusion Criteria for Stage 2:\n\n          -  Infants who have received breastfeeding or other infant formula (powder) during\n             hospitalization other than SSC with calories  intake  \u226525% of the required daily\n             total calories\n\n          -  Infants who have planned to receive breastfeeding or other infant formula (powder)\n             other than NeoSure after discharge with calories intake \u226525% of the required daily\n             total calories"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "21 Days", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Hospital based preterm infants"
            }
        }, 
        "enrollment": {
            "#text": "900", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02073071", 
            "org_study_id": "DA05"
        }, 
        "intervention": {
            "arm_group_label": "Preterm/low birth weight infants", 
            "description": "Commercially available preterm infant formula", 
            "intervention_name": "Preterm infant formula per standard of care", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 26, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Xiamen", 
                        "country": "China", 
                        "state": "Fujian"
                    }, 
                    "name": "Xiamen Maternity and Child Health Care Hospital,"
                }, 
                "investigator": {
                    "last_name": "LIN Xinzhu, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong"
                    }, 
                    "name": "The First Affiliated Hospital, Sun Yat-sen University"
                }, 
                "investigator": {
                    "last_name": "ZHUANG Siqi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Changsha", 
                        "country": "China", 
                        "state": "Hunan"
                    }, 
                    "name": "The Second Xiangya Hospital of Central South University"
                }, 
                "investigator": {
                    "last_name": "CHEN Pingyang, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China", 
                        "state": "Jiangsu"
                    }, 
                    "name": "Nanjing Children's Hospital"
                }, 
                "investigator": {
                    "last_name": "ZHOU Xiaoguang, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Peking University First Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "FENG Qi, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "WANG Ying, MD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China"
                    }, 
                    "name": "Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine"
                }, 
                "investigator": {
                    "last_name": "SUN Jianhua, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China"
                    }, 
                    "name": "Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine"
                }, 
                "investigator": {
                    "last_name": "CAI Wei, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants", 
        "overall_contact": {
            "email": "kristen.deluca@abbott.com", 
            "last_name": "Kristen DeLuca, MS, RD", 
            "phone": "614-624-5455"
        }, 
        "overall_contact_backup": {
            "email": "bobbie.swearengin@abbott.com", 
            "last_name": "Bobbie Swearengin, RN", 
            "phone": "614-624-7182"
        }, 
        "overall_official": {
            "affiliation": "Abbott Nutrition China", 
            "last_name": "Xianfeng Zhao, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Weight", 
            "safety_issue": "No", 
            "time_frame": "Change from first feeding to discharge (up to ~8 weeks)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02073071"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Length", 
                "safety_issue": "No", 
                "time_frame": "Change from first feeding to discharge  (up to ~8 weeks)"
            }, 
            {
                "measure": "Head Circumference", 
                "safety_issue": "No", 
                "time_frame": "Change from first feeding to discharge  (up to ~8 weeks)"
            }, 
            {
                "measure": "Hospitalization Length of Stay", 
                "safety_issue": "No", 
                "time_frame": "Time from Birth to discharge  (up to ~8 weeks)"
            }, 
            {
                "description": "vomiting, abdominal distension, gastric residuals, stool abnormalities, necrotizing enterocolitis", 
                "measure": "Gastrointestinal Tolerance", 
                "safety_issue": "No", 
                "time_frame": "From first feeding to discharge  (up to ~8 weeks)"
            }, 
            {
                "description": "From discharge to the time point that infant's weight >or= 25th percentile of growth expectation based on corrected age (P25) or until infant reaches 9 months corrected age.", 
                "measure": "Catch Up Growth", 
                "safety_issue": "No", 
                "time_frame": "From discharge to 9 months corrected age"
            }
        ], 
        "source": "Abbott Nutrition", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott Nutrition", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}